Skip to main content
Retour
Watch Compare

United Health Products, Inc.

Qualité des données : 100%
UEEC
OTC Manufacturing Measuring & Analyzing Instruments
0,09 €
▲ 0,02 € (33,59%)
6 months return
—
Momentum
Neutral
Free cash flow
-815 253,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,02
Interest Coverage-32,29

Valorisation

PE (TTM)
-3,31
En dessous de la moyenne du secteur (-1,50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -815 253,0

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) 0,0 Net Income (TTM) -3,83 M
ROE N/A ROA -4356,54%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -815 253,0
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,02
Debt / Equity N/A Current Ratio 0,02
Interest Coverage -32,29 Asset Turnover 0,00
Working Capital -1,96 M Tangible Book Value -3,36 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -3,31 · EV/EBITDA: N/A
P/E Ratio -3,31 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6,43%
Market Cap 12,68 M Enterprise Value 13,60 M

Per Share

EPS: -0,02 · FCF/Share: 0,00
EPS (Diluted TTM) -0,02 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 21,28% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 21,28%
SBC-Adj. FCF -815 253 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0,0 0,0 37 500,0 59,0 643,0
Net Income -2,00 M -2,62 M -1,69 M -30,55 M -15,71 M
EPS (Diluted) -0,01 — — — —
Gross Profit — 0,0 18 856,0 34,0 448,0
Operating Income -2,01 M -2,43 M -2,80 M -29,80 M -14,85 M
EBITDA — — — — —
R&D Expenses 355 936,0 598 810,0 624 564,0 237 458,0 245 218,0
SG&A Expenses 1,65 M 1,83 M 2,20 M 29,56 M 14,60 M
D&A 4 050,0 4 050,0 — — —
Interest Expense 32 322,0 40 512,0 17 022,0 226 139,0 210 025,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 269 979,0 284 643,0 350 528,0 26 799,0 217 100,0
Total Liabilities 2,71 M 2,00 M 2,42 M 1,17 M 1,17 M
Shareholders' Equity -2,44 M -1,71 M -2,06 M -1,14 M -953 262,0
Total Debt — — — — —
Cash & Equivalents — — 13 377,0 21 799,0 46 076,0
Current Assets 191 683,0 151 822,0 71 039,0 26 799,0 115 750,0
Current Liabilities 1,64 M 1,95 M 2,42 M 1,17 M 1,17 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -3,3 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3